Drug intelligence / Profile preview

modified ovine submaxillary gland mucin

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes
Administration
Intramuscular, Subcutaneous
01

Overview

Modified ovine submaxillary gland mucin refers to a chemically or enzymatically altered form of the native glycoprotein mucin derived from the submaxillary glands of sheep (ovine). The most common modification is desialylation, resulting in dOSM, which removes sialic acid residues and alters immunogenic properties. Ovine submaxillary gland mucins are large, heavily glycosylated proteins rich in O-linked oligosaccharides. They have been studied as immunogens in cancer vaccine research due to their expression of tumor-associated carbohydrate antigens such as sialyl-Tn (sTn) and Tn antigens. Modified forms have been used experimentally to stimulate immune responses against carcinoma cells by presenting these antigens more effectively. Mechanistically, they act primarily as antigen sources for immune activation rather than through direct receptor targeting[6][8].

Other names
modified OSMmodified ovine submaxillary mucinOSM (modified)dOSM (desialylated ovine submaxillary mucin)
02

Targets

Mucin–mucin self-interfaceTn (Tn antigen)

Beyond the preview

Go deeper on modified ovine submaxillary gland mucin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on modified ovine submaxillary gland mucin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call